SCHEMBL853777

SCHEMBL853777

CCCC(CC(=O)OCC)c1c[nH]c2ccc(O)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.43
SPR P35270 3/20 0.41
PKM P14618 1/20 0.41
ALDH1A1 P00352 4/20 0.40
LMNA P02545 3/20 0.40
NFKB1 P19838 3/20 0.40
NPSR1 Q6W5P4 3/20 0.40
HPGD P15428 3/20 0.40
TSHR P16473 2/20 0.40
PMP22 Q01453 2/20 0.40
CYP2C9 P11712 2/20 0.40
GLA P06280 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
KDM4E B2RXH2 3/20 0.39
MAPT P10636 3/20 0.39
KMT2A Q03164 2/20 0.39
HSD17B10 Q99714 2/20 0.39
HTR1D P28221 2/20 0.39
HTR1A P08908 2/20 0.39
HTR2A P28223 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL852664 0.87 KDM4E (0.41) GAAPKMALDH1A1HPGDCYP2C9
SCHEMBL8387335 0.84 PKM (0.55) GAAPKMALDH1A1CYP2C9KDM4E
SCHEMBL852764 0.84 HDAC3 (0.48) LMNAKDM4EMAPT
SCHEMBL853701 0.82 TRPM8 (0.55) ALDH1A1LMNAHPGDKDM4EMAPT
SCHEMBL853940 0.81 GAA (0.49) GAAPKMALDH1A1LMNANFKB1
SCHEMBL853413 0.78 GAA (0.48) GAASPRALDH1A1LMNANFKB1
SCHEMBL6694052 0.77 PKM (0.37) GAAPKMALDH1A1LMNAHPGD
SCHEMBL9672135 0.77 MTNR1A (0.53) GAAALDH1A1LMNANPSR1HPGD
SCHEMBL5851184 0.76 GPR84 (0.62) SPRALDH1A1LMNANFKB1NPSR1
SCHEMBL5177499 0.74 PKM (0.68) SPRPKMALDH1A1LMNANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed